Summary:
The primary objective of this study is to determine whether a experimental drug called RESLIZUMAB administered once every 4 weeks, is more effective than a placebo in improving lung function.
Qualified Participants Must:
• Be between 12 and 25 years of age
•
Have a previous diagnosis of Asthma
•
Be currently taking, FLUTICASON
•
Be on a stable dose for 30 days before Screening
•
Must have a negative pregnancy test before Screening
Qualified Participants May Receive:
Qualified participants will recieve, a comensation of $50 dollars per each completed visit.